Charles Schwab holder plans Rule 144 stock sale

Charles Schwab Corp filed a notice of proposed sale of 2,917,998 shares of its common stock under Rule 144.

Rhea-AI Filing Summary

Charles Schwab Corp filed a notice of proposed sale of 2,917,998 shares of its common stock under Rule 144. The filing lists prior equity compensation grants in the form of Restricted Stock Awards from 2017 through 2025, with individual grants ranging from a few thousand to over 76,000 shares. The issuer reports 319,353,919 common shares outstanding in connection with this planned resale.

Key Figures

Shares to be sold: 2,917,998 shares Shares outstanding: 319,353,919 shares CIK: 168573 +3 more

6 metrics

Shares to be sold 2,917,998 shares Proposed Rule 144 sale of Charles Schwab Corp common stock

Shares outstanding 319,353,919 shares Charles Schwab Corp common shares outstanding referenced with the sale

CIK 168573 Issuer identifier for Charles Schwab Corp

Largest RSA grant 76,453 shares Restricted Stock Award dated 05/10/2024

RSA grant 2017 8,020 shares Restricted Stock Award dated 05/15/2017

RSA grant 2025 40,258 shares Restricted Stock Award dated 05/05/2025

Key Terms

Rule 144, Restricted Stock Award, Equity Compensation, Form 144

4 terms

Rule 144 regulatory

"notice of proposed sale of shares under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Award financial

"lists prior equity compensation grants in the form of Restricted Stock Awards"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

Equity Compensation financial

"Restricted Stock Award | Issuer | | | 76453 | 05/10/2024 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Form 144 regulatory

"Charles Schwab Corp filed a notice of proposed sale on Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing related to AMRX disclose about Charles Schwab stock?

It discloses a proposed Rule 144 sale of 2,917,998 Charles Schwab Corp common shares. The filing also lists historical Restricted Stock Award grants that are the source of the shares being sold.

How many Charles Schwab common shares are outstanding according to this Form 144 linked with AMRX?

The issuer reports 319,353,919 Charles Schwab Corp common shares outstanding. This figure provides context for the planned Rule 144 sale of 2,917,998 shares noted in the filing.

What types of awards underpin the Charles Schwab shares in this Form 144 associated with AMRX?

The shares arise from multiple Restricted Stock Awards granted as Equity Compensation between 2017 and 2025. Each award reflects common stock granted by the issuer that can now be sold under Rule 144.

Over what period were the equity awards in this Charles Schwab Form 144 granted, as referenced for AMRX?

The filing lists Restricted Stock Awards dated 05/15/2017, 05/03/2018, 05/08/2019, 05/05/2021, 05/10/2024, and 05/05/2025. These historical grants collectively support the proposed Rule 144 stock sale.

How many shares were in the largest Restricted Stock Award in the Charles Schwab Form 144 linked with AMRX?

The largest individual Restricted Stock Award shown is for 76,453 shares of Charles Schwab common stock, dated 05/10/2024. Other awards range from 3,281 to 46,218 shares across earlier grant dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/11/2026 - 12:32 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001209726
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Amneal Pharmaceuticals, Inc.
SEC File Number	001-38485
Address of Issuer	400 CROSSING BLVD BRIDGEWATER NEW JERSEY 08807
Phone	(908) 947-3120
Name of Person for Whose Account the Securities are To Be Sold	BUCHI J KEVIN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp 3000 Schwab Way Westlake TX 76262	168573	2917998.00	319353919	08/11/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2017	Restricted Stock Award	Issuer			8020	05/15/2017	Equity Compensation
Common	05/03/2018	Restricted Stock Award	Issuer			3281	05/03/2018	Equity Compensation
Common	05/08/2019	Restricted Stock Award	Issuer			6107	05/08/2019	Equity Compensation
Common	05/05/2021	Restricted Stock Award	Issuer			46218	05/05/2021	Equity Compensation
Common	05/10/2024	Restricted Stock Award	Issuer			76453	05/10/2024	Equity Compensation
Common	05/05/2025	Restricted Stock Award	Issuer			40258	05/05/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Account Title: Memorandum of Trust of J. Kevin Buchi U/A DTD 11/04/2021 J. Kevin Buchi as trustee
Date of Notice	08/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	J. Kevin Buchi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)